oxcarbazepine 150 mg
1 INDICATIONS AND USAGE Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine tablets are indicated for: • Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures • Pediatrics: o Monotherapy in the treatment of partial-onset seizures in children 4 to 16 years o Adjunctive therapy in the treatment of partial-onset seizures in children 2 to 16 years ( 1 )
Glenmark Pharmaceuticals Inc., USA
Related Pills
oxcarbazepine 600 mg
Glenmark Generics Inc., USA
oxcarbazepine 150 mg
Glenmark Pharmaceuticals Inc., USA
oxcarbazepine 300 mg
glenmark pharmaceuticals inc., usa
oxcarbazepine 600 mg
Glenmark Generics Inc., USA
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 150 mg film-coated Tablets: yellow, film-coated oval, biconvex tablets with a deep break line on both sides and "G" engraved on one side of the deep break line on one side of the tablet and "13" and "7" engraved on either side of the deep break line on the other side of the tablet. Bottle of 100.........NDC 68462-137-01 Bottle of 500.........NDC 68462-137-05 300 mg film-coated Tablets: yellow, film-coated oval, biconvex tablets with a deep break line on both sides and "G" and "4" engraved on either side of the deep break line on one side of the tablet. Bottle of 100.........NDC 68462-138-01 Bottle of 500.........NDC 68462-138-05 600 mg film-coated Tablets: yellow, film-coated oval, biconvex tablets with a deep break line on both sides and "G" engraved on one side of the deep break line on one side of the tablet and "13" and "9" engraved on either side of the deep break line on the other side of the tablet. Bottle of 100.........NDC 68462-139-01 Bottle of 500.........NDC 68462-139-05 Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in tight container (USP).
More pills like OVAL 13 7 G